We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$891M
AUM Growth
+$97.8M
Cap. Flow
+$10.2M
Cap. Flow %
1.14%
Top 10 Hldgs %
29.98%
Holding
153
New
7
Increased
75
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$2.2M
2
PARA
Paramount Global Class B
PARA
+$1.85M
3
PFE icon
Pfizer
PFE
+$1.84M
4
FDX icon
FedEx
FDX
+$1.32M
5
EXP icon
Eagle Materials
EXP
+$1.25M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.75M
2
T icon
AT&T
T
+$1.67M
3
FTNT icon
Fortinet
FTNT
+$1.51M
4
BUD
ANHEUSER BUSCH COS INC
BUD
+$1.33M
5
FICO icon
Fair Isaac
FICO
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Healthcare 16.63%
3 Consumer Discretionary 11.81%
4 Financials 10.81%
5 Communication Services 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
51
IQVIA
IQV
$38.4B
$6.14M 0.69%
21,753
+999
+5% +$259K
INTC icon
52
Intel
INTC
$459B
$6.09M 0.68%
118,172
-814
-0.7% -$41.6K
CTAS icon
53
Cintas
CTAS
$81.6B
$5.67M 0.64%
51,188
-1,088
-2% -$117K
EOG icon
54
EOG Resources
EOG
$77.6B
$5.6M 0.63%
63,076
+8,291
+15% +$745K
GPN icon
55
Global Payments
GPN
$23.6B
$5.5M 0.62%
40,720
+5,280
+15% +$728K
BMY icon
56
Bristol-Myers Squibb
BMY
$134B
$4.89M 0.55%
78,379
-29,813
-28% -$1.75M
ICSH icon
57
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.12B
$4.8M 0.54%
95,328
-9,048
-9% -$456K
ABBV icon
58
AbbVie
ABBV
$433B
$4.61M 0.52%
34,077
-3
-0% -$354
ZTS icon
59
Zoetis
ZTS
$32.3B
$4.15M 0.47%
16,999
-150
-0.9% -$32.9K
ABTX
60
DELISTED
Allegiance Bancshares
ABTX
$4.15M 0.47%
98,243
-24,312
-20% -$993K
HAS icon
61
Hasbro
HAS
$12.9B
$4.06M 0.46%
39,869
+3,557
+10% +$341K
SCHE icon
62
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$4M 0.45%
134,893
+33,149
+33% +$1.01M
BKNG icon
63
Booking.com
BKNG
$149B
$3.92M 0.44%
40,875
+250
+0.6% +$23.7K
CTVA icon
64
Corteva
CTVA
$50.9B
$3.75M 0.42%
79,375
+14,636
+23% +$667K
CRM icon
65
Salesforce
CRM
$152B
$3.72M 0.42%
14,654
+1,203
+9% +$338K
SLB icon
66
SLB Ltd
SLB
$73.2B
$3.6M 0.4%
120,338
+7,788
+7% +$245K
DFS
67
DELISTED
Discover Financial Services
DFS
$3.49M 0.39%
30,225
– –
WELL icon
68
Welltower
WELL
$168B
$3.34M 0.37%
38,891
+4,684
+14% +$390K
VRSK icon
69
Verisk Analytics
VRSK
$25.1B
$3.31M 0.37%
14,476
+359
+3% +$78.3K
TRI icon
70
Thomson Reuters
TRI
$44.4B
$3.27M 0.37%
25,910
– –
KO icon
71
Coca-Cola
KO
$374B
$3.21M 0.36%
54,177
-24
-0% -$1.34K
NTRS icon
72
Northern Trust
NTRS
$33.3B
$3.04M 0.34%
25,415
+1,214
+5% +$145K
AXP icon
73
American Express
AXP
$233B
$2.9M 0.33%
17,716
+1
+0% +$171
BNS icon
74
Scotiabank
BNS
$108B
$2.67M 0.3%
37,267
+2,436
+7% +$161K
WDAY icon
75
Workday
WDAY
$40.8B
$2.52M 0.28%
9,238
+956
+12% +$265K
1 2
3
4 5

Similar funds

SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Callahan Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Callahan Advisors held 153 positions worth $891M, up 12% from $794M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Callahan Advisors's Q4 2021 filing shows 7 new, 75 increased, 46 reduced and 5 closed positions. Its largest new stake was Paramount Global Class B: 53,775 shares worth $1.62M. The largest sale was Bristol-Myers Squibb, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Callahan Advisors's largest Q4 2021 buy was Paramount Global Class B: 53,775 shares worth $1.62M.
  • Callahan Advisors added most to D.R. Horton in Q4 2021, an estimated $2.2M increase.
  • Callahan Advisors's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $1.75M.
  • Callahan Advisors fully exited ANHEUSER BUSCH COS INC in Q4 2021, selling an estimated $1.33M.
  • Callahan Advisors's ten largest holdings make up 30% of its $891M portfolio in Q4 2021.
  • Callahan Advisors opened 7 new positions and closed 5 in Q4 2021.
  • Callahan Advisors's portfolio value rose 12% quarter-over-quarter to $891M.

Based on Callahan Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.